Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 14, 2022, titled Glenmark inks agreement with Astrazeneca to commercialize its product Pulmicort Respules in Columbia.
Archies Limited has informed the Exchange about Copy of Newspaper Publication
Royal Orchid Hotels Limited has informed the Exchange about Copy of Newspaper Publication
Kernex Microsystems (India) Limited has informed the Exchange regarding Board meeting held on February 12, 2022.
Technofab Engineering Limited has informed the Exchange regarding Withdrawal of Notice for reclassification of shareholding from Promoter and Promoter Group Category to Public Category as per Regulation 31A of SEBI (LODR) Regulations.
Shree Renuka Sugars Limited has informed the Exchange about Loss of Share Certificates
Welspun Enterprises Limited has informed the Exchange regarding allotment of 769000 securities pursuant to ESOP/ESPS at its meeting held on February 12, 2022
Jindal Steel & Power Limited has informed the Exchange about Schedule of meet
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
